TAXOTERE (docetaxel) receives 2 new European approvals for treatment of breast cancer

TAXOTERE (docetaxel) receives 2 new European approvals for treatment of breast cancer Paris, France – 11 January 2005 – Sanofi-aventis announced today that the European Commission has approved 2 new indications for Taxotere® (docetaxel) Injection Concentrate for treatment of breast cancer. See attached press release ------------------------------------------------------------ Ytterligere informasjon kan hentes på følgende hjemmeside: http://www.waymaker.no Nedenstående filer kan lastes ned: http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=62900&fn=wkr0020.pdf Press release